Zobrazeno 1 - 3
of 3
pro vyhledávání: '"AM Gonzalez Rodriguez"'
Autor:
F. Pérez Hernández, R Mesa Expósito, I González García, Mdp Díaz Ruiz, E Tevar Afonso, M Suarez Gonzalez, FJ Merino Alonso, AM Gonzalez Rodriguez, CL Diaz Diaz, MA Navarro Dávila
Publikováno v:
Section 5: Patient Safety and Quality Assurance.
Background Obeticholic acid (OCA) is a synthetically modified bile acid that is used to treat a rare disease, the primary biliary cholangitis (PBC). OCA has been recently used in combination with ursodeoxycholic acid (UDCA) in adults who have not res
Autor:
I Rodríguez Penín, L Fuster Sanjurjo, MJ Garcia Verde, AM Gonzalez Rodriguez, I Rodriguez Legazpi
Publikováno v:
European Journal of Hospital Pharmacy. 22:A121.3-A122
Background Desensitisation has been used for some decades now so that patients can be treated with the drug causing the hypersensitivity reaction when an alternative drug with similar efficacy/safety is not available. Purpose To describe the pemetrex
Autor:
MJ Garcia Verde, I Rodriguez Legazpi, I Rodríguez Penín, L Fuster Sanjurjo, AM Gonzalez Rodriguez
Publikováno v:
European Journal of Hospital Pharmacy. 22:A89.1-A89
Background Toxic epidermal necrolysis (TEN) is a rare but severe cutaneous adverse reaction with a high rate of mortality and morbidity. Purpose To report a case of TEN after abiraterone and zoledronic acid exposure. Material and methods Retrospectiv